newsfilter
← Latest News
Business Wire·

VBI Vaccines Appoints Vaughn Himes to Board of Directors

VBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that Vaughn B. Himes, Ph.D., Chief Technical